Primary mediastinal large B-cell lymphoma diagnostic study of choice
|
Xyz Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Primary mediastinal large B-cell lymphoma diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Primary mediastinal large B-cell lymphoma diagnostic study of choice |
|
FDA on Primary mediastinal large B-cell lymphoma diagnostic study of choice |
|
CDC on Primary mediastinal large B-cell lymphoma diagnostic study of choice |
|
Primary mediastinal large B-cell lymphoma diagnostic study of choice in the news |
|
Blogs on Primary mediastinal large B-cell lymphoma diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
The diagnosis of primary mediastinal lymphoma is primarily based on biopsy findings, followed by immunophenotype and surfae markers.
Diagnostic Study of Choice
Biopsy is the diagnostic study of choice.
Study of choice
Biopsy:
- The diagnosis of primary mediastinal large B cell lymphoma relies on the exclusion of adequate tissue, which offers most difficulty due to the location of the tumor, therefore an excisional biopsy is usually not possible.
- Therefore, surgical biopsy is highly preferred.[1]
- Due to fibrosis, needle aspirates are often paucicellular and fail to provide information about the tissue.
- Small biopsies may be non-diagnostic because the lesion is not sampled adequately or because crush artifact or extensive necrosis, fibrosis, or cystic change obscures the diagnostic lesion.
- Similarly, core biopsies mostly contain fibrotic tissue or tumor cells that are disrupted and not useful.
- To obtain sufficient tissue for biopsy , patients usually undergo either one of the following techniques:[1]